Development of ligands for the peripheral benzodiazepine receptor

Michelle L James1, Silvia Selleri, Michael Kassiou

  • 1Department of Pharmacology, University of Sydney, NSW 2006, Australia.

Insights

Peripheral benzodiazepine receptors (PBR) are key indicators of brain disease activity. Developing selective PBR ligands is crucial for understanding neuroinflammation and developing new diagnostics and therapeutics.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Peripheral benzodiazepine receptor (PBR) is highly expressed in peripheral organs and moderately in the healthy brain.
  • Activated microglial cells are the primary PBR expressers in CNS pathology.
  • PBR over-expression during neuroinflammation indicates its potential as a brain disease activity index.

Purpose of the Study:

  • To review current classes of PBR ligands.
  • To discuss the biological activity and therapeutic potential of PBR ligands.
  • To highlight the need for selective PBR ligands for further research.

Main Methods:

  • Review of existing literature on PBR ligands.
  • Analysis of different classes of PBR ligands including benzodiazepines, isoquinoline carboxamides, indoleacetamides, phenoxyphenyl-acetamides, and pyrazolopyrimidines.
  • Discussion of synthesized analogues for improved affinity and kinetics.

Main Results:

  • Several classes of PBR ligands have been developed, including benzodiazepines, isoquinoline carboxamides, indoleacetamides, phenoxyphenyl-acetamides, and pyrazolopyrimidines.
  • Conformationally restrained analogues show promise for enhanced affinity and brain kinetics.
  • PBR is implicated in cell proliferation, apoptosis, steroidogenesis, porphyrin transport, and immunomodulation, though its precise physiological role remains unclear.

Conclusions:

  • PBR is a significant target for therapeutic and diagnostic development in CNS pathology.
  • Selective PBR ligands are essential for elucidating PBR's physiological role and underlying pathological pathways.
  • Further research with novel PBR ligands may reveal PBR subtypes and precise localization.

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Ligand-gated Ion Channels01:19

Ligand-gated Ion Channels

Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.